Security key
462260100
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA)
CUSIP: 462260100
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 220,039,758
- Total 13F value
- $378,480,610
- Share change
- -19,345,465
- Put/Call ratio
- 101%
- SEC-reported price per share
- $1.72
- Number of holders
- 244
- Value change
- -$103,966,458
- Number of buys
- 125
- Number of sells
- 151
- Shares outstanding
- 415,431,143
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
244
Top holders
10
IOVA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
IOVANCE BIOTHERAPEUTICS, INC. SEC filings
IOVANCE BIOTHERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 462260100
Recent filing periods:
Ownership snapshot
Top reported holders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
13D/G
3/4/5
Lead comparable stake: 6.4%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 6.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
6.4%
PERCEPTIVE ADVISORS LLC
3.8%
Matthew William Rosinack
0.02%
VANGUARD GROUP INC
6.7%
MHR FUND MANAGEMENT LLC
5.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
6.4%
from 13D/G
|
$80,967,543
24,314,578 shares
|
— | 31 Mar 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
3.8%
|
$45,599,285
12,808,788 shares
|
-$33,120,382 | 31 Mar 2025 |
| Matthew William Rosinack |
3/4/5
SVP, Finance (Int. PFO & PAO)
|
0.02%
|
$153,382
89,129 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
6.7%
|
$92,500,000
27,777,778 shares
|
— | 31 Mar 2025 |
| MHR FUND MANAGEMENT LLC |
13F
Company
|
5.9%
|
$81,308,953
24,417,103 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
2.7%
|
$36,767,602
11,041,322 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
244
Shares
220,039,758
Rows available
244
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
292
Q2 2025 holders
244
Holder diff
-48
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend